Unknown NA INTERVENTIONAL 2-arm NCT01445925

Substrate Ablation and Remodelling in Non-paroxysmal Atrial Fibrillation (AF) (SMAAN-PAF)

Substrate Modification With Ablation and Antiarrhythmic Drugs in Non-Paroxysmal Atrial Fibrillation

Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust

Interventions Pharmacological Substrate modification Pulmonary vein isolation (PVI) Pulmonary vein isolation + linear lesions

Updated 5 times since 2017 Last updated: Aug 21, 2013 Started: Sep 30, 2011 Primary completion: Nov 30, 2014 Completion: Nov 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Atrial Fibrillation and is currently ongoing. Liverpool Heart and Chest Hospital NHS Foundation Trust leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Liverpool Heart and Chest Hospital NHS Foundation Trust

Data source: Liverpool Heart and Chest Hospital NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Liverpool, United Kingdom
• London, United Kingdom